Literature DB >> 19301140

Hematologic abnormalities following renal transplantation.

Mark A Marinella1.   

Abstract

Recipients of renal allografts are surviving longer and, consequently, may experience a variety of complications related not only to the transplanted kidney, but also to the hematopoietic system. Common hematologic complications in the renal transplant patient include abnormalities of one cell line, such as post-transplantation erythrocytosis or anemia, that are often treatable with simple measures. Conversely, pathologies involving the leukocyte and platelet population often exist in the context of pancytopenia, which may be a manifestation of systemic infection (e.g., cytomegalovirus, human herpesvirus 8) or malignancy (post-transplantation lymphoproliferative disorders). Uncommon, but life-threatening, processes complicating renal transplantation include hepatosplenic gammadelta T-cell lymphoma and viral-induced hemophagocytic syndrome, both of which are associated with severe pancytopenia and, often, death. Since this patient population is often managed in a multidisciplinary fashion by nephrologists, infection specialists, transplant surgeons, hematologists, and internal medicine physicians, a succinct review of this topic is warranted.

Entities:  

Mesh:

Year:  2009        PMID: 19301140     DOI: 10.1007/s11255-009-9558-5

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.266


  102 in total

Review 1.  Genetics of drug response to immunosuppressive treatment and prospects for personalized therapy.

Authors:  R Danesi; M Mosca; U Boggi; F Mosca; M Del Tacca
Journal:  Mol Med Today       Date:  2000-12

2.  Parvovirus B19 infection-associated red-cell aplasia in renal-transplant recipients: clues from the bone marrow.

Authors:  Gurjeewan Garewal; Jasmina Ahluwalia; Neelam Varma; Reena Das; Vinay K Sakhuja
Journal:  Transplantation       Date:  2004-01-27       Impact factor: 4.939

3.  Angiotensin-converting enzyme inhibition induces apoptosis in erythroid precursors and affects insulin-like growth factor-1 in posttransplantation erythrocytosis.

Authors:  Daniel Glicklich; Larry Burris; Agnes Urban; Vivian Tellis; Stuart Greenstein; Richard Schechner; Prasad Devarajan; Helena Croizat
Journal:  J Am Soc Nephrol       Date:  2001-09       Impact factor: 10.121

4.  Effects of losartan or enalapril on hemoglobin, circulating erythropoietin, and insulin-like growth factor-1 in patients with and without posttransplant erythrocytosis.

Authors:  Angela Yee Moon Wang; Alex Wai Yin Yu; Christopher Wai Kei Lam; Ly Mee Yu; Philip Kam Tao Li; Juliana Goh; Siu Fai Lui
Journal:  Am J Kidney Dis       Date:  2002-03       Impact factor: 8.860

Review 5.  Post-transplant hepatosplenic T-cell lymphoma successfully treated with HyperCVAD regimen.

Authors:  Siok-Keen Tey; Paula V Marlton; Carmel M Hawley; Debra Norris; Devinder S Gill
Journal:  Am J Hematol       Date:  2008-04       Impact factor: 10.047

Review 6.  Thrombotic microangiopathy in renal transplantation.

Authors:  Carlos Chiurchiu; Piero Ruggenenti; Giuseppe Remuzzi
Journal:  Ann Transplant       Date:  2002       Impact factor: 1.530

7.  Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?

Authors:  V Leblond; F Davi; F Charlotte; R Dorent; M O Bitker; L Sutton; I Gandjbakhch; J L Binet; M Raphael
Journal:  J Clin Oncol       Date:  1998-06       Impact factor: 44.544

8.  Neutrophil dysplasia characterised by a pseudo-Pelger-Huet anomaly occurring with the use of mycophenolate mofetil and ganciclovir following renal transplantation: a report of five cases.

Authors:  Glen A Kennedy; Troy D Kay; David W Johnson; Carmel M Hawley; Scott B Campbell; Nikky M Isbel; Paula Marlton; Ralph Cobcroft; Devinder Gill; Gavin Cull
Journal:  Pathology       Date:  2002-06       Impact factor: 5.306

9.  Postrenal transplant erythrocytosis: a review of 53 patients.

Authors:  C G Wickre; D J Norman; A Bennison; J M Barry; W M Bennett
Journal:  Kidney Int       Date:  1983-05       Impact factor: 10.612

10.  Reduction of blood loss from laboratory testing in hospitalized adult patients using small-volume (pediatric) tubes.

Authors:  Francisco Sanchez-Giron; Francisco Alvarez-Mora
Journal:  Arch Pathol Lab Med       Date:  2008-12       Impact factor: 5.534

View more
  5 in total

1.  Longitudinal Evaluation of Cytopenias in the Renal Transplant Population.

Authors:  Aileen C Johnson; Geeta Karadkhele; Wairimu Magua; Payas Vasanth; Christian P Larsen
Journal:  Transplant Direct       Date:  2022-05-26

2.  [The erythrocytosis after renal transplantation: a retrospective study about 11 recipients ].

Authors:  Zbiti Najoua; Rhou Hakima; Benamar Loubna; Ezaitouni Fatima; Bayahia Rabia; Ouzeddoun Naima
Journal:  Pan Afr Med J       Date:  2010-04-29

Review 3.  Blood disorders typically associated with renal transplantation.

Authors:  Yu Yang; Bo Yu; Yun Chen
Journal:  Front Cell Dev Biol       Date:  2015-03-19

4.  Risk Factors for Erythrocytosis in Renal Transplantation: Is Ganciclovir Therapy One of Them?

Authors:  Fatma Özge Kayhan Koçak; Musa Bali
Journal:  Ann Transplant       Date:  2022-08-19       Impact factor: 1.479

5.  Hairy cell leukemia in kidney transplantation: lesson from a rare disorder.

Authors:  Fabrizio Vinante; Paola Tomei; Gianluigi Zaza; Alberto Zamò; Antonio Lupo
Journal:  Exp Hematol Oncol       Date:  2013-08-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.